Appt of Pain Relief Adviser

Futura Medical PLC
23 August 2007




For immediate release                                             23 August 2007



                               Futura Medical Plc

                          ('Futura' or 'the Company')

                     Appointment of Adviser on Pain Relief



Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative
products for the consumer healthcare market, is pleased to announce the
appointment of Professor Robert Moore DSc as an advisory consultant to the
Company in the therapeutic area of pain relief. Prof Moore's extensive
experience of pain relief, from both academic and commercial perspectives, is
expected to be of great value in the development of TPR100, Futura's topical
treatment for the provision of pain relief.



Prof Moore, a former Consultant Biochemist at the Radcliffe Infirmary, Oxford,
has published many scientific articles. He moved into industry in 1985 as
managing director of the UK division of a US diagnostics company, taking it from
six to 250 employees and achieving profitability. In 1994, he established his
own healthcare consultancy, which has worked for many of the world's leading
pharmaceutical companies, and he has also advised Government.



Prof Moore is the founder and Editor-in-Chief of Bandolier, an independent
journal on evidence based healthcare whose electronic version,
www.ebandolier.com, receives more than one million visitors each month.  In
1994, he was appointed Honorary Professor at the Department of Health Sciences,
University of Wales.



James Barder, Futura's Chief Executive, said: 'I am delighted to welcome a
scientific adviser of Prof Moore's calibre to Futura. His huge breadth of
experience, particularly in the area of pain relief, will be of great value in
the development of TPR100, our pipeline product that uses our topical
trans-dermal delivery technology, DermaSys(R).'





For any further information please contact:


Futura Medical plc
James Barder, Chief Executive                          Tel: [phone]
mail to: [e-mail]                www.futuramedical.co.uk


Canaccord Adams                                        Tel: [phone]
Mark Ashurst



For any media enquiries please contact:
Buchanan Communications                               Tel: [phone]
Mark Court / Rebecca Dietrich



Notes



Futura Medical plc



Futura Medical is a pharmaceutical group that develops innovative products for
consumer healthcare.  The Company is developing a portfolio of products and its
strategy is to license their manufacture and distribution to major
pharmaceutical and healthcare groups.



Futura is based in Guildford, Surrey, and its shares trade on the AIM market of
the London Stock Exchange.



www.futuramedical.co.uk


                      This information is provided by RNS
            The company news service from the London Stock Exchange